Correction to: A novel SLC8A1/LINC01913 intergenic region-ALK fusion identified by NGS and validated by IHC and FISH in a stage IIB lung adenocarcinoma patient who remains relapse-free during the treatment of crizotinib: A case report.
Invest New Drugs
; 40(6): 1357, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-35972630
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Invest New Drugs
Year:
2022
Type:
Article
Affiliation country:
China